Dr. Alicia True Dagrosa, MD

Dr. Dagrosa practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.

Dr. Dagrosa's NPI, 1336671510, was assigned on March 28, 2017. Dr. Dagrosa holds New Hampshire license 20873.

Dr. Dagrosa's primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.

Dr. Dagrosa's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Dagrosa to 2 more medical groups, each named with a free account. Dr. Dagrosa's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dagrosa practices. Vendor and product names are available with a free account.

Dermatology is Dr. Dagrosa's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Dagrosa is licensed in New Hampshire.

CMS data shows 2,772 Medicare services from Dr. Dagrosa across 16 procedure codes in 2024, for 953 Medicare patients. Medicare paid $89,016 for them.

CMS counts 953 Medicare patients who saw Dr. Dagrosa in 2024. The largest group is 65 to 74, with 462 patients. 55% of them have high blood pressure, and 53% have high cholesterol. 7% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dagrosa's median patient age at 63, with 62% women.

In 2024, Dr. Dagrosa wrote 524 Medicare Part D claims for 235 patients. 90% of them were for generic drugs. CMS names the drug for 390 of them, across 15 drugs with 11 or more claims each, at $101,910 in total drug cost. In 2023, CMS named 363 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Dagrosa for performance year 2024, reported through an alternative payment model (APM). Dr. Dagrosa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dagrosa as offering telehealth. CMS counts 860 procedures of removal of skin lesions by Dr. Dagrosa, more than 92% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Dagrosa, published from 2019 to 2025. 2019 was the busiest year, with 2. The most frequent topics are Curriculum, Dermatology and Education, Medical, Undergraduate. Dr. Dagrosa has published most often in Am J Dermatopathol. Dr. Dagrosa's most frequent co-authors are Dorothea Torti Barton, MD, Michael Shane Chapman, MD and Gabrielle Eugenie Duprat, MD.

CMS Open Payments shows 1 general payment to Dr. Dagrosa from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. Celgene Corporation paid the most, $65.